A Phase 2/3, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of GX-19N, A COVID-19 Preventive DNA Vaccine in Healthy Individuals
Tahapan Penelitian : Complete
Sponsor:
PT Kalbe Farma
Mitra Pelaksana:
not specified
No Registry
INA-5L15LDW
Tanggal Input Registry : 19-07-2024
Tracking Information | |
---|---|
Tanggal Antisipasi Studi | 01-01-2021 |
Outcome Primer | not specified |
Outcome Skunder | |
Descriptive Information | |
Judul Penelitian Popular | A Phase 2/3, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of GX-19N, A COVID-19 Preventive DNA Vaccine in Healthy Individuals |
Judul Penelitian Ilmiah | A Phase 2/3, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of GX-19N, A COVID-19 Preventive DNA Vaccine in Healthy Individuals |
Jenis Penelitian | Interventional |
Intervensi | GX-19N, A COVID-19 Preventive DNA Vaccine |
Jumlah Subyek Penelitian | 5 |
Recruitment Information | |
Eligibility Criteria | Inclusion Criteria: not specifiedExclusion Criteria: not specified |
Administrative Information | |
Nomor Persetujuan Etik | not specified |
Nomor Persetujuan Material Transfer Agreement | Not applicable |
Nomor Persetujuan Pelaksanaan Uji Klinik | PPUK/PPUB number |
Other Study ID Numbers | |
Contact Person | not specified |